The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3745-3749

  Cavalier, Etienne ^a   Daly, Adrian F ^a   Betea, Daniela ^a   Pruteanu Apetrii, Pamela Nicoleta ^a   Delanaye, Pierre ^a   Stubbs, Phil ^b   Bradwell, Arthur R ^b   Chapelle, Jean Paul ^a   Beckers, Albert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID CARCINOMA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 77955391070     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2791     Document Type: Article

References (20)

1. Thompson SD, Prichard AJ 2004 The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 12:93-97
2. Shane E 2001 Parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493
3. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1999 Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538-544
4. Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP 2008 Parathyroid carcinoma. J Bone Miner Res 23:1869-1880
5. Grimelius L, Johansson H 1997 Pathology of parathyroid tumors. Semin Surg Oncol 13:142-154
6. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P 1998 A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809
7. Quarles LD, Lobaugh B, Murphy G 1992 Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150
8. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y 1995 Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844
9. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H 1999 A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290
10. D'Amour P, Brossard JH, Rousseau L, Roy L, Gao P, Cantor T 2003 Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 49:2037-2044
11. Rubin MR, Silverberg SJ, D'Amour P, Brossard JH, Rousseau L, Sliney Jr J, Cantor T, Bilezikian JP 2007 An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma. Clin Chem 53:1470-1476
12. nd generation PTH ratio in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 70:533-538
13. Rakel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P 2005 Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clin Endocrinol (Oxf) 62:721-727
14. Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, Daly AF, Beckers A 2004 Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab 89:3413-3420
15. Bradwell AR, Harvey TC 1999 Control of hypercalcaemia of parathyroid carcinoma by immunisation. Lancet 353:370-373
16. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A 2000 A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761
17. Nguyen-Yamamoto L, Rousseau L, Brossard JH, Lepage R, D'Amour P 2001 Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology 142:1386-1392
18. Divieti P, John MR, Jüppner H, Bringhurst FR 2002 Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 143:171-176
19. Divieti P, Geller AI, Suliman G, Jüppner H, Bringhurst FR 2005 Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 146:1863-1870
20. Blachowicz A, Chudzinski W, Nawrot I, Kryszalowicz B, Spiechowicz U, Szmidt J, Wiecek A, Franek E 2008 Serum 1-84 and 7-84 parathyroid hormone concentrations and bone in patients with primary hyperparathyroidism. Langenbecks Arch Surg 393:709-713